Unknown NA INTERVENTIONAL 3-arm NCT04827628

Effect of Oryza Sativa l Extract to LPS, ZO-1, and Intestinal Microbiota in Obese Individuals

Effect of Oryza Sativa l Extract to Serum Lipopolysaccharide, Tight Junction Protein 1 (ZO-1), and Intestinal Microbiota Expression Among Obese Individual

Sponsor: Hasanuddin University

Conditions Obesity

Interventions Control Oryza Sativa Extract

Updated 4 times since 2021 Last updated: Apr 1, 2021 Started: Apr 10, 2021 Primary completion: May 1, 2021 Completion: Jun 1, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Obesity, this trial is ongoing. The trial is conducted by Hasanuddin University and has accumulated 4 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
May 2023 — Jul 2024 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
May 2021 — May 2023 [monthly]

Not Yet Recruiting NA

First recorded

Apr 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hasanuddin University

Data source: Hasanuddin University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Makassar, Indonesia